A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)
NCT07794774
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
197
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Berobenatide
OTHER:
Placebo
Sponsor
Pfizer